A blood sample is analyzed using advanced hematology analyzers that detect immature platelets based on residual RNA content.

High IPF indicates increased platelet production, often seen in conditions with platelet destruction or recovery after bone marrow suppression.

Low IPF suggests reduced platelet production, often due to bone marrow failure or suppression.

Yes, it is safe and can be performed in pediatric patients when clinically indicated.

Without IPF testing, the cause of thrombocytopenia may remain unclear, delaying appropriate treatment.

Prevention depends on managing underlying conditions; IPF reflects bone marrow activity rather than a preventable factor.

High IPF is seen in immune thrombocytopenia, recovery after chemotherapy, or increased platelet destruction.

Low IPF is associated with aplastic anemia, bone marrow suppression, or severe marrow dysfunction.